The largest database of trusted experimental protocols

4 protocols using hutmec

1

Evaluation of Angiogenic Potential

Check if the same lab product or an alternative is used in the 5 most similar protocols
HTR8/SVneo cells were transfected with si‐IGF‐1 or oe‐IGF‐1 plasmids, and the supernatant was collected and settled to a 96‐well plate containing 1.5 × 104 human uterine microvascular endothelial cells (HUtMEC; PromoCell), which were coated with matrix gel. After 16 h, the HUtMEC branch was observed under an optical microscope and photographed. The total number of branch points and branch tubes was manually calculated from photomicrography.
+ Open protocol
+ Expand
2

Effects of Botulinum Toxin A on Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein cells (HUVEC, ATCC) and human uterine microvascular endothelial cells (HUtMEC, PromoCell) were maintained in EGMTM-2 endometrial cell growth medium 2 (Lonza) and endothelial cell growth medium MV (PromoCell), respectively. Ishikawa (ATCC) and CRL-4003 cells (kindly gifted from the laboratory of Dr. Haeng Seok Song) were maintained in DMEM/F12 media (Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (Gibco, Grand Island, NY, USA) and 1% penicillin-streptomycin (Gibco, Grand Island, NY, USA) as previously described [27 (link)]. All experiments were conducted using cells of the passages between 1 and 10. For the analyses for the effects of BoTA, cells were treated with commercially available BoTA (Botulax, Hugel, Seoul, Korea) for 24h, 48h, or 72h at concentration of 0.5, 2.0, 10, or 20IU. Botulax is the type for Clostridium botulinum toxin A derived from the strain of Clostridium Botulinum CBFC26, and for the utilization of BoTA from Botulax (Hugel) to perform the all analyses, the powder form of BoTA was dissolved and diluted in sterile 0.9% saline solution.
+ Open protocol
+ Expand
3

Angiogenic Potential of dNK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MACS enriched CD56+ dNK cells were cultured with rhTGFb or SB. Conditioned supernatants were collected and added to 96-well plates coated with Matrigel containing 1.5 × 104 Human Uterine Microvascular Endothelial Cells (HUtMEC; PromoCell). After 16 h, HUtMEC branching was examined by light contrast microscopy and images were captured. Total number of branching points and tubes were counted manually from the photomicrography.
+ Open protocol
+ Expand
4

Endothelial Cell Culture and BoTA Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture and Botulinum Toxin A treatment.
Human Umbilical Vein Cells (HUVEC, ATCC) and Human Uterine Microvascular Endothelial Cells (HUtMEC, PromoCell) were maintained in EGM TM -2 endometrial cell growth medium 2 (Lonza) and Endothelial Cell Growth Medium MV (PromoCell) respectively. Ishikawa (ATCC) and CRL-4003 cells (kindly gifted from the laboratory of Dr. Haeng Seok Song) were maintained in DMEM/F12 media (Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (Gibco, Grand Island, NY, USA) and 1% penicillin-streptomycin (Gibco, Grand Island, NY, USA) as previously described [28] . All experiments were conducted using cells of the passages between 1 and 10. For the analyses for the effects of BoTA, cells were treated with commercially available BoTA (Botulax, Hugel, Seoul, Korea) for 24h, 48h or 72h at concentration of 0.5, 2.0, 10, or 20IU. Botulax is the type for Clostridium Botulinum Toxin A derived from the strain of Clostridium Botulinum CBFC26 and for the utilization of BoTA from Botulax (Hugel) to perform the all analyses, the powder form of BoTA was dissolved and diluted in sterile 0.9% Saline solution.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!